a public good project by the
Synthesis
Company
of California

© 2026

Computational drug repurposing to predict approved and novel drug-disease associations | doi.page

0 citations0 references

Google Scholar doi.org

Computational drug repurposing to predict approved and novel drug-disease associations

Journal of Molecular Graphics and Modelling·2018·Vol. 85, pp. 91–96

Citations Over TimeTop 14% of 2018 papers

Zoya Khalid, Osman Uğur Sezerman

Related Papers

→ COVID-19 therapeutics: Clinical application of repurposed drugs and futuristic strategies for target-based drug discovery(2023)22 cited
→ Worldwide Publication Trends of Drug Repurposing and Drug Repositioning in the Science of Medicine (2003-2022)(2023)5 cited
→ Drug Repurposing Screen for Compounds Inhibiting the Cytopathic Effect of SARS-CoV-2(2020)30 cited
Machine Learning and Computational Approach to Repurposing FDA Approved Drugs(2020)
→ P62 SIMPATHIC: accelerating drug repurposing for rare neurological, neurometabolic and neuromuscular disorders by exploiting SIMilarities in clinical and molecular PATHology(2023)